ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 154 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $411,000 | -22.0% | 11,220 | -0.9% | 0.01% | -23.1% |
Q2 2019 | $527,000 | -8.0% | 11,322 | -20.7% | 0.01% | -7.1% |
Q1 2019 | $573,000 | -9.9% | 14,280 | +3.2% | 0.01% | -22.2% |
Q4 2018 | $636,000 | -13.9% | 13,838 | -16.9% | 0.02% | 0.0% |
Q3 2018 | $739,000 | +749.4% | 16,660 | +653.8% | 0.02% | +800.0% |
Q2 2018 | $87,000 | -94.4% | 2,210 | -89.7% | 0.00% | -95.2% |
Q1 2018 | $1,552,000 | +353.8% | 21,454 | +312.4% | 0.04% | +366.7% |
Q4 2017 | $342,000 | -24.0% | 5,202 | -42.0% | 0.01% | -30.8% |
Q3 2017 | $450,000 | -3.4% | 8,976 | -10.8% | 0.01% | -7.1% |
Q2 2017 | $466,000 | -1.9% | 10,064 | -25.3% | 0.01% | -6.7% |
Q1 2017 | $475,000 | +181.1% | 13,464 | 0.0% | 0.02% | +150.0% |
Q4 2016 | $169,000 | – | 13,464 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |